Santos, P.; Sá Filho, A.S.; Aprigliano, V.; Duarte, A.G.; Ribeiro, N.A.; Lombardo, K.M.; Fajemiroye, J.O.; Buchholz, A.P.; Vaz, V.R.; Chiappa, G.R.
Liraglutide and Exenatide in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes. Pharmaceutics 2026, 18, 69.
https://doi.org/10.3390/pharmaceutics18010069
AMA Style
Santos P, Sá Filho AS, Aprigliano V, Duarte AG, Ribeiro NA, Lombardo KM, Fajemiroye JO, Buchholz AP, Vaz VR, Chiappa GR.
Liraglutide and Exenatide in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes. Pharmaceutics. 2026; 18(1):69.
https://doi.org/10.3390/pharmaceutics18010069
Chicago/Turabian Style
Santos, Paula, Alberto Souza Sá Filho, Vicente Aprigliano, Amanda G. Duarte, Natã Alegransi Ribeiro, Katia Marques Lombardo, James Oluwagbamigbe Fajemiroye, Artur Prediger Buchholz, Victor Renault Vaz, and Gaspar R. Chiappa.
2026. "Liraglutide and Exenatide in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes" Pharmaceutics 18, no. 1: 69.
https://doi.org/10.3390/pharmaceutics18010069
APA Style
Santos, P., Sá Filho, A. S., Aprigliano, V., Duarte, A. G., Ribeiro, N. A., Lombardo, K. M., Fajemiroye, J. O., Buchholz, A. P., Vaz, V. R., & Chiappa, G. R.
(2026). Liraglutide and Exenatide in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes. Pharmaceutics, 18(1), 69.
https://doi.org/10.3390/pharmaceutics18010069
